• Skip to main content

  • Home
  • News
    • New Funds
    • New Financings
    • People On the Move
    • Trends and Strategies
  • Transactions
    • New Platforms
    • New Add Ons
    • New Exits
  • Briefly
  • 2025 Salary Survey
  • Member Center
Please enter your username/email.
Please enter your password.
Login
Something went wrong. Please check your entries and try again.
PEP-logo-v9
Flag-small-6-28-24-120x73

August 19, 2026

Private equity's news leader since 2007

Chicago, Illinois

pep-superman-header-80x105-1

"There is a right and a wrong in the universe, and that distinction is not hard to make."

Superman

  • About Us
  • Membership
  • Webinars
  • Store
  • FAQs
  • Advertise With Us
  • Contact Us
Search

Archives for January 30, 2024

Got Chapped Lips? Get ChapStick

January 30, 2024 by John McNulty

Suave Brands, a portfolio company of Yellow Wood Partners, has agreed to acquire the ChapStick brand from publicly traded Haleon for $430 million and a passive minority interest in the Suave Brands.

ChapStick functions as both a sunscreen and as a skin lubricant to help prevent and protect chafed, chapped, sunburned, cracked, and windburned lips. Ingredients used in ChapStick products include camphor, beeswax, menthol, petroleum jelly, vitamin E, and aloe. According to Yellow Wood, ChapStick is a leader in the lip care product category and is the #1 brand by volume with over 80% brand awareness. ChapStick had $142 million in revenue in fiscal 2023.

Source: ChapStick

The history of ChapStick dates to the early 1880s when Dr. Charles Browne Fleet invented ChapStick as a lip balm product. In 1912, the product was purchased by John Morton and became part of the Morton Manufacturing Corporation. In 1963, A.H. Robins Company acquired ChapStick from Morton Manufacturing with Robins and Chapstick later being acquired by American Home Products (AHP) in 1988. AHP changed its name to Wyeth in 2002 and was acquired by Pfizer in 2009. Haleon (NYSE: HLN) acquired ChapStick from Pfizer in 2019.

Suave’s branded products are used by women, men, and children and include shampoos, conditioners, treatments and serums, body washes, antiperspirants and deodorants, and skin care lotions. According to the company, led by CEO Daniel Alter, Suave products are found in one out of every two United States households.

“ChapStick is the #1 lip care brand in the mass, drug, food and convenience store channels,” said Dana Schmaltz, a partner at Yellow Wood. “Chapstick products are purchased by one out of every five households in the United States; consumers love the brand. Chapstick has the highest brand awareness in lip care, as well as the strongest purchase conversion among all brands in the category. Similar to Suave, ChapStick will benefit from Suave Brands’ leadership, setting the brand up for continued innovation and growth driven by increased consumer marketing investments, as well as a more focused sales approach. We look forward to completing this transaction in the first half of 2024.”

“The Yellow Wood team established Suave Brands Company in May 2023 to acquire the Suave brand from Unilever,” said Mr. Alter. “We saw the opportunity to grow Suave with a more focused management approach while also creating the corporate infrastructure to acquire and manage additional personal care brands across multiple categories to drive synergies across the platform. We are excited to add ChapStick, another leading brand with deep equity and history, into our platform.”

Headquartered near New York City in Englewood Cliffs, New Jersey, Suave was founded in the 1930s and was one of the first brands to bring salon-quality hair care to the public. Today, Suave products are sold through mass retailers, grocery stores, drug retailers, and ecommerce platforms.

“ChapStick will be Yellow Wood’s fifth corporate carveout transaction in the past four years,” said Tad Yanagi, a partner at Yellow Wood. “The firm prides itself on having become a trusted partner to CPG companies to carve brands out and set them up for their next stage of growth. We appreciate Haleon’s collaboration on all levels and look forward to working with them to complete the carveout expeditiously.”

Yellow Wood invests in consumer brands and companies that operate in the mass, drug, food, specialty, value, club, and e-commerce channels, and have EBITDA from $10 million and $50 million.

In December 2023, Yellow Wood announced the pending acquisition of the Elida Beauty portfolio of brands from Unilever. This platform includes leading brands such as Q-Tips, Caress, TiGi, Ponds, St. Ives, and Noxzema, as well as European brands including Brut, Impulse, Monsavon, and Timotei.

In April 2022, Yellow Wood closed Yellow Wood Capital Partners III LP at its hard cap with $750 million of limited partner capital commitments. Fund III was oversubscribed and included commitments from many of Yellow Wood’s long-time limited partners. Yellow Wood’s earlier fund, Yellow Wood Capital Partners II LP, closed in July 2017 with an oversubscribed $370 million of committed capital.

Haleon (NYSE: HLN) is a provider of consumer health products with leading brands – Advil, Sensodyne, Panadol, Theraflu, Polident, and Centrum – in oral health, pain relief, respiratory health, digestive health, vitamins, minerals and supplements. The company was created in 2022 when GlaxoSmithKline Consumer Healthcare spun out of GlaxoSmithKline in 2022.

© 2024 Private Equity Professional | January 30, 2024

Filed Under: New Platform, Transactions

Cyprium Backs Pharmacy Services Provider

January 30, 2024 by John McNulty

Cyprium has made a subordinated debt and minority equity investment in OneroRx, a provider of pharmacy services.

OneroRx provides retail, specialty and tele pharmacy services and medical supplies to individuals, regional hospitals, senior living facilities, long-term care facilities and group homes in rural counties and urban areas across the Midwest that have historically been underserved by the large national chains. The company fills over 3 million prescriptions annually to patients in 6 states through 65 locations.

OneroRx has grown through both greenfield expansion and add-on acquisitions of single- and multi-locations including several during the past year. The company, led by President and CEO Joseph Dunham II, is headquartered in West Des Moines, Iowa.

“We strongly believe in the importance of providing continued local access to comprehensive pharmacy services,” said Mr. Dunham. “Our strategy is to continue expanding our footprint to combat the increasing number of pharmacy deserts in the US, and this transaction provides us with the capital needed to execute our growth plan.”

“I was incredibly impressed by the skill and dedication of OneroRx’s management team and employees,” said Beth Haas, a partner at Cyprium. “The company’s ability to offer vital services at affordable prices is an essential component of improving patient outcomes and we are thrilled to support them in this endeavor.”

Cyprium provides subordinated debt, preferred and common stock as a minority investor to family, founder, and entrepreneur-owned companies for growth, shareholder dividends and buyouts, ESOPs, and minority recapitalizations. The firm invests from $5 million to $60 million per transaction in North American-based companies that at least $4 million in EBITDA.

Cyprium – with offices in Cleveland, New York, and Chicago – was formed in 2011 when the investment team of Key Principal Partners – which was formed in 2008 – spun out from financial services firm KeyCorp to form Cyprium. In April 2020, Cyprium closed its fifth fund, Cyprium Investors V LP, with $445 million of committed capital.

© 2024 Private Equity Professional | January 30, 2024

Filed Under: New Platform, Transactions

Arsenal Invests in Polycorp

January 30, 2024 by John McNulty

Arsenal Capital Partners has closed its acquisition of Polycorp, a manufacturer of engineered elastomers.

Elastomers are polymers that are highly elastic and capable of returning to their original shape after being stretched or deformed. Engineered elastomers are materials with modified chemical compositions, molecular structures, or processing methods to achieve specific performance characteristics. These modifications can enhance properties like strength, durability, elasticity, and resistance to environmental factors.

Source: Polycorp

Polycorp’s designs and manufactures engineered polymer products, including rubber- and polyurethane- based elastomers, which are used to reduce corrosion, abrasion, vibration, and noise in applications in the mining, rail, infrastructure and industrial sectors.

Polycorp has more than 220 employees and sells its products through a direct sales force and a network of sales agents worldwide. The company operates a 100,000 square-foot facility and headquarters that is located west of Toronto in Elora, Ontario. Polycorp was founded in 1996 by Peter Snucins to acquire the former assets of BFGoodrich Engineering Products of Canada.

Source: Polycorp

“The transaction with Arsenal will accelerate Polycorp’s strategic growth initiatives and enable additional investment in our manufacturing and R&D capabilities, human capital, and strategic acquisitions,” said Mr. Snucins. “I am especially excited to partner with Arsenal given the firm’s established track record of building leading materials technology businesses in the elastomers sector.” Following the closing, Mr. Snucins will remain as an investor and board member of Polycorp.

“The company’s portfolio of capabilities is a natural fit for Arsenal, given our previous successful experiences investing in elastomeric and polymeric technologies, such as rubber and polyurethanes,” said Brett Schneider, an operating partner at Arsenal.

New York-headquartered Arsenal invests in middle-market specialty industrial and healthcare companies that have $100 million to $500 million of enterprise value. Since its founding in 2000, Arsenal has raised total capital of $10 billion, closed more than 290 platform and add-on acquisitions, and exited more than 35 portfolio companies.

“We are excited to partner with Polycorp given the company’s best-in-class elastomeric technologies and customer service capabilities,” added Dan Bruck, a principal of Arsenal.

William Blair & Company was the financial advisor to Polycorp and Harris Williams was the financial advisor to Arsenal.

© 2024 Private Equity Professional | January 30, 2024

Filed Under: New Platform, Transactions

Angeles Continues Build of Robotics Integration Platform

January 30, 2024 by John McNulty

Angeles Equity Partners has acquired Acieta, an industrial robotics manufacturer and integrator, from Mitsui & Co. This is the fourth acquisition by Angeles as it assembles its RōBEX robotics integration platform.

Angeles acquired RōBEX in March 2022 and quickly added-on with the buy of Mid-State Engineering, an automation integrator specializing in mechanical and electrical engineering. Eight months later, in November 2022, RōBEX acquired Michigan-based Vantage Corporation, an industrial robotics manufacturer and integrator.

Acieta is a full-service robotics provider with systems, controls, and software engineering capabilities. The company, with 115 employees, was founded in 1983 and over the past 40 years has built a large standard products business and installed over 5,500 robots. Acieta is a FANUC Authorized System Integrator, Certified Vision Specialist, and Certified Servicing Integrator.

Source: Acieta

Acieta is led by CEO Robby Komljenovic and is headquartered near Milwaukee in Waukesha, Wisconsin. Acieta’s has a combined 67,000 square-feet of manufacturing facilities in Council Bluffs, Iowa, and Waukesha, Wisconsin (headquarters).

“Our team is eager to help build what we believe is the country’s most technically capable and experienced automation systems integrator,” said Mr. Komljenovic. “This combination is designed to provide our customers an expanded reach, additional resources, and what we view as unmatched industry experience to advise on optimizing all processes to maximize returns on their robotic equipment investments.”

RōBEX is a designer, fabricator, and installer of robotic systems for customers in the consumer goods and logistics industries. The company is an authorized system integrator for FANUC and a key distributor for Mobile Industrial Robots (MiR), Plus One Robotics, AutoGuide Mobile Robots, and Seegrid autonomous mobile robots. RōBEX, led by CEO Jon Parker, is located near Toledo in Perrysburg, Ohio, with a fabrication and service center near Richmond in Aylett, Virginia.

The acquisition of Acieta expands Robex’s equipment tending, welding, and palletizing capabilities across a broader set of end markets including agriculture, foundry and die, welding and fabrication, and construction and building products. Now combined, RōBEX, Mid-State, Vantage, and Acieta have a total of 207,000 square-feet of manufacturing facilities with locations in Ohio, Virginia, Indiana, Michigan, Wisconsin, Iowa.

Source: Acieta

“We are excited about the combination of these two great companies and believe in the ongoing growth trajectory of this industry,” said Sam Heischuber, a managing director at Angeles Equity. “As the manufacturing and logistics sectors continue to face labor shortages, higher wages, intensifying global competition, and increased manufacturing complexity, the need for a sophisticated, robotics automation systems integrator with a national presence should only increase.”

Los Angeles-based Angeles Equity makes control investments in companies with enterprise values up to $200 million that have headquarters and primary operations in the United States and Canada. Sectors of interest include aerospace, automotive, building products, capital goods, chemicals, electronics, manufacturing, metals, transportation and logistics, packaging, and distribution.

Lincoln International was the financial advisor to Acieta on this transaction.

© 2024 Private Equity Professional | January 30, 2024

Filed Under: Add-on, Transactions

PEP_mainlogo_White

Private Equity Professional
c/o Sun Business Media
PO Box 6610
Evanston, Illinois 60204
Office Direct (847) 920-8010

[email protected]

News

  • Platforms
  • Add Ons
  • Exits
  • Funds
  • Financings
  • People
  • Strategies

Customer Help

  • Why Advertise?
  • PEP Media Kit

Memberships

  • Individual

Advertising

  • Why Advertise?
  • PEP Media Kit

© 2026 Private Equity Professional. All Rights Reserved.